Refreshing results…
Tumor-derived Lysophosphatidic Acid Blunts Protective Type-I Interferon Responses in Ovarian Cancer
Download from aacrjournals.orgImmunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
Download from www.nature.comMissing publications? Search for publications with a matching author name.